Polymeropoulos Mihael Hristos 4
4 · Vanda Pharmaceuticals Inc. · Filed May 19, 2025
Insider Transaction Report
Form 4
Polymeropoulos Mihael Hristos
DirectorPresident and CEOOther
Transactions
- Purchase
Common Stock
2025-05-16$4.22/sh+20,000$84,472→ 2,315,731 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.22 to $4.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.